Journal of Hematology & Oncology

official impact factor 2.93

This article is part of the supplement: Current trends in leukemia, lymphoma, myeloma and ITP: updates and highlights from ASH 2008

Open Access Meeting abstract

Recent progress in the treatment of multiple myeloma: updates and highlights from ASH 2008

Sundar Jagannath

Journal of Hematology & Oncology 2009, 2(Suppl 1):A4 doi:10.1186/1756-8722-2-S1-A4

No comments have yet been made on this article.

Post a comment